Page last updated: 2024-12-08
barium selenate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
barium selenate: long-acting parenteral selenium supplement for sheep; RN given refers to [1:1]salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 134655 |
MeSH ID | M0124480 |
Synonyms (14)
Synonym |
---|
xew84xni9u , |
unii-xew84xni9u |
selenic acid, barium salt (1:1) |
einecs 232-113-8 |
7787-41-9 |
barium selenate |
barium(2+) selenate |
A840348 |
AKOS015916364 |
Q4413544 |
selenic acid,bariumsalt(1:1) |
DTXSID90884432 |
barium(2+);selenate |
barium selenate(vi) |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" Cattle had regular blood sampling to assay Se, from 8 days before dosing to 1155 days afterwards." | ( Depot injection of barium selenate for long-term prevention of selenium inadequacy in beef cattle. Babidge, PJ; Judson, GJ, 2010) | 0.69 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (14)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (35.71) | 18.7374 |
1990's | 3 (21.43) | 18.2507 |
2000's | 2 (14.29) | 29.6817 |
2010's | 4 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 24.96
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (24.96) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (12.50%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |